Literature DB >> 26115979

Patient Selection in Short Stay Total Hip Arthroplasty for Medicare Patients.

Scott T Lovald1, Kevin L Ong2, Edmund C Lau1, Girish P Joshi3, Steven M Kurtz2, Arthur L Malkani4.   

Abstract

There is a trend towards shortening inpatient hospital stays following total hip arthroplasty (THA) in an effort to reduce healthcare costs and potentially decrease complications. The purpose of this study was to identify patients who are at risk for readmission, complications, and mortality after short stay THA. The Medicare sample (1997-2011) was used to identify THA patients with 1-2-day (Group A, n=2949) or 3-day (Group B, n=8707) stays. Complication risks were similar between groups, though there was a reduced risk for hospitalization for Group A (adjusted hazard ratio=0.90, P=0.029). These findings suggest that age and comorbidities, particularly diabetes and cardiovascular conditions, have the greatest effect on readmission and event risk after short stay THA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complications; length of stay; readmission; short-stay; total hip arthroplasty

Mesh:

Year:  2015        PMID: 26115979     DOI: 10.1016/j.arth.2015.05.040

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

Review 1.  Patient selection criteria for outpatient joint arthroplasty.

Authors:  Nanne P Kort; Yoeri F L Bemelmans; P Hugo M van der Kuy; Jacqueline Jansen; Martijn G M Schotanus
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-22       Impact factor: 4.342

2.  Association between same day discharge total knee and total hip arthroplasty and risks of cardiac/pulmonary complications and readmission: a population-based observational study.

Authors:  Jiabin Liu; Nabil Elkassabany; Jashvant Poeran; Alejandro Gonzalez Della Valle; David H Kim; Daniel Maalouf; Stavros Memtsoudis
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.